secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001645666-25-000029
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kezar shareholders elect directors, approve say-on-pay, ratify KPMG; two directors face majority withhold
--------------------------------------------------------------------------------

- Elizabeth Garner elected as Class I director with 2,148,505 votes for; Michael Kauffman and Courtney Wallace also elected despite more withheld votes than for.
- Advisory vote on executive compensation approved with 2,151,745 for (54.7%), 1,781,942 against, 7,980 abstain; broker non-votes 2,240,480.
- Ratification of KPMG as auditor for 2025 passed with 6,116,820 for, 56,801 against, 8,526 abstain.
- High withhold votes for Kauffman (2,322,932 withheld vs 1,618,735 for) and Wallace (2,390,314 withheld vs 1,551,353 for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000164566625000029/0001645666-25-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000164566625000029/kzr-20250617.htm
  HTML page:      https://secwatch.observer/filing/0001645666-25-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer